stockrowPediatrix Medical Group, Inc.
MD Healthcare Medical Care Facilities
Pediatrix Medical Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 4.92% from fiscal 2024.
- Revenue
- +1.72%
- EPS
- −27.6%
- Free cash flow
- −14.4%
- Total debt
- −4.11%
Quarter to September 2026, against a year earlier
Follow MD
Alert me
Pediatrix Medical Group, Inc. (MD) Revenue
Pediatrix Medical Group, Inc.'s revenue for fiscal 2025 was $1.9B, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $2.0B. Over the past ten years it has ranged from $1.7B (fiscal 2018) to $3.3B (fiscal 2017); the current reading is higher than 45% of that period. Pediatrix Medical Group, Inc. ranks 22nd of 47 Medical Care Facilities companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $1.9B | (4.92%) |
| FY2024 | $2.0B | 0.92% |
| FY2023 | $2.0B | 1.15% |
| FY2022 | $2.0B | 3.18% |
| FY2021 | $1.9B | 10.22% |
| FY2020 | $1.7B | (2.57%) |
| FY2019 | $1.8B | 3.29% |
| FY2018 | $1.7B | (47.04%) |
| FY2017 | $3.3B | 2.21% |
| FY2016 | $3.2B | 14.50% |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $501.4M | 2.79% |
| Jun 2026 | $487.8M | 2.43% |
| Mar 2026 | $476.2M | (3.56%) |
| Dec 2025 | $493.8M | 0.18% |
| 43 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| ASTH Astrana Health, Inc. compare | $3.8B |
| ACHC Acadia Healthcare Company, Inc. compare | $3.4B |
| SGRY Surgery Partners, Inc. compare | $3.4B |
| BKD Brookdale Senior Living Inc. compare | $3.1B |
| AVAH Aveanna Healthcare Holdings Inc. compare | $2.6B |
| MD Pediatrix Medical Group, Inc. | $2.0B |
| NHC National HealthCare Corporation compare | $1.6B |
| ADUS Addus HomeCare Corporation compare | $1.5B |
| GRDN Guardian Pharmacy Services, Inc. compare | $1.5B |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on MD
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement